The
FGFR2 gene encodes keratinocyte growth factor receptor involved in the proliferation of keratinocytes and wound healing, while the TNFA gene encodes a wellknown proinflammatory cytokine.
As for the role of FGFR in lens regeneration, the bek isoform of
FGFR2 was shown to be present in Xenopus epidermis only in regions where the epidermis was capable of transdifferentiating into lenses (Arresta et al., 2005).
We decided to investigate the expression of both
FGFR2 isoforms in ASCs, through absolute quantification of transcripts by qRT-PCR.
Sequence analysis was performed on 2 exons (exons 7-8) of the
FGFR2 gene in 85 cases referred for pre-diagnosis of craniosynostosis between 2010 and 2016.
The group of Florence Bareyre has shown that FGF22 signalling via FGFR1 and
FGFR2 is essential for the formation of these new synapses [82].
(c) ln RR: regression coefficients of each SNP from simple logistic regression, adjusted for age, menarche, menopause, family history, pregnancy, histology, treatment, the
FGFR2 GWAS-identified SNP, and deleterious variants in ATM, BRCA1, BRCA2, CHECK2, and offset term.
AKT1 CTNNB1 FGFR1 GNAS KRAS NRAS PIK3R5 STAT1 AKT2 EGFR
FGFR2 HRAS MAP2K1 NTRK1 PKHD1 TEC AKT3 ERBB2 FGFR3 IDH1 MAP2K2 NTRK2 PRKCB1 TP53 (HER2) ALK ERCC6 FGFR4 IDH2 MAP2K7 NTRK3 RAF1 BRAF FBX4 FOXL2 IGF1R MET PDGFRA RET CDK4 FBXW7 GNA11 KDR MYC PIK3R1 SMO CSF1R FES GNAQ KIT NEK9 PIK3R4 SOS1
The differences in the EDAR and
FGFR2 genes were identified last year and are thought to have occurred as part of the evolution of Asian populations following their prehistoric divergence from Europeans.
The majority of family clusters are not attributable to any of these high-risk susceptibility genes and attention has recently turned to 'low-risk' genes such as
FGFR2 and TNCR9, which may collectively be responsible for up to 25% of familial breast cancer [32].
Novel roles of
Fgfr2 in AER differentiation and positioning of the dorsoventral limb interface.
The company added that BLU-554 (CS3008) is an oral, potent highly selective and irreversible inhibitor of FGFR4, with a precise selectivity for FGFR4 that spares the paralog kinases FGFR1,
FGFR2 and FGFR3.